JAZZ logo

Jazz Pharmaceuticals (JAZZ) Operating expenses

annual operating expenses:

$2.90B+$95.56M(+3.41%)
December 31, 2024

Summary

  • As of today (May 21, 2025), JAZZ annual total operating expenses is $2.90 billion, with the most recent change of +$95.56 million (+3.41%) on December 31, 2024.
  • During the last 3 years, JAZZ annual operating expenses has risen by +$413.41 million (+16.65%).
  • JAZZ annual operating expenses is now at all-time high.

Performance

JAZZ Operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

quarterly operating expenses:

$849.11M+$80.42M(+10.46%)
March 1, 2025

Summary

  • As of today (May 21, 2025), JAZZ quarterly total operating expenses is $849.11 million, with the most recent change of +$80.42 million (+10.46%) on March 1, 2025.
  • Over the past year, JAZZ quarterly operating expenses has increased by +$118.82 million (+16.27%).
  • JAZZ quarterly operating expenses is now at all-time high.

Performance

JAZZ quarterly operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

Operating expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

JAZZ Operating expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+3.4%+16.3%
3 y3 years+16.6%+39.0%
5 y5 years+108.2%+137.6%

JAZZ Operating expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+16.6%at high+39.0%
5 y5-yearat high+108.2%at high+154.8%
alltimeall timeat high+3798.8%at high+3583.8%

JAZZ Operating expenses History

DateAnnualQuarterly
Mar 2025
-
$849.11M(+10.5%)
Dec 2024
$2.90B(+3.4%)
$768.69M(+12.5%)
Sep 2024
-
$683.15M(-4.4%)
Jun 2024
-
$714.48M(-2.2%)
Mar 2024
-
$730.29M(-4.4%)
Dec 2023
$2.80B(+7.5%)
$764.20M(+9.5%)
Sep 2023
-
$697.60M(-0.6%)
Jun 2023
-
$702.14M(+10.2%)
Mar 2023
-
$637.11M(-8.1%)
Dec 2022
$2.61B(+5.0%)
$693.14M(+6.9%)
Sep 2022
-
$648.58M(-0.8%)
Jun 2022
-
$653.98M(+7.1%)
Mar 2022
-
$610.89M(-14.1%)
Dec 2021
$2.48B(+71.4%)
$711.20M(+7.0%)
Sep 2021
-
$664.52M(-5.4%)
Jun 2021
-
$702.21M(+73.3%)
Mar 2021
-
$405.27M(-0.2%)
Dec 2020
$1.45B(+4.1%)
$405.95M(+15.1%)
Sep 2020
-
$352.59M(+5.8%)
Jun 2020
-
$333.30M(-6.7%)
Mar 2020
-
$357.35M(-26.3%)
Dec 2019
$1.39B(+25.2%)
$485.15M(+50.9%)
Sep 2019
-
$321.42M(+7.2%)
Jun 2019
-
$299.97M(+5.3%)
Mar 2019
-
$284.94M(+7.5%)
Dec 2018
$1.11B(+24.3%)
$265.06M(+4.3%)
Sep 2018
-
$254.02M(-5.8%)
Jun 2018
-
$269.67M(-16.5%)
Mar 2018
-
$322.89M(+23.3%)
Dec 2017
$894.66M(+16.6%)
$261.95M(+19.5%)
Sep 2017
-
$219.20M(+10.3%)
Jun 2017
-
$198.67M(-7.5%)
Mar 2017
-
$214.85M(+8.8%)
Dec 2016
$767.18M(+12.4%)
$197.46M(-0.6%)
Sep 2016
-
$198.62M(+5.4%)
Jun 2016
-
$188.45M(+3.2%)
Mar 2016
-
$182.66M(+2.2%)
DateAnnualQuarterly
Dec 2015
$682.53M(+10.5%)
$178.70M(-1.2%)
Sep 2015
-
$180.96M(+14.1%)
Jun 2015
-
$158.63M(-3.4%)
Mar 2015
-
$164.25M(+1.2%)
Dec 2014
$617.88M(+45.4%)
$162.23M(+10.7%)
Sep 2014
-
$146.55M(-4.5%)
Jun 2014
-
$153.44M(-1.4%)
Mar 2014
-
$155.65M(+34.6%)
Dec 2013
$424.98M(+37.2%)
$115.63M(+8.7%)
Sep 2013
-
$106.36M(+0.2%)
Jun 2013
-
$106.16M(+9.6%)
Mar 2013
-
$96.83M(+6.9%)
Dec 2012
$309.71M(+137.3%)
$90.56M(+3.4%)
Sep 2012
-
$87.59M(+20.8%)
Jun 2012
-
$72.52M(+22.8%)
Mar 2012
-
$59.05M(+40.6%)
Dec 2011
$130.50M(+27.4%)
$42.01M(+17.7%)
Sep 2011
-
$35.69M(+30.5%)
Jun 2011
-
$27.34M(+7.3%)
Mar 2011
-
$25.47M(+10.5%)
Dec 2010
$102.43M(-0.4%)
$23.05M(-15.3%)
Sep 2010
-
$27.22M(+0.4%)
Jun 2010
-
$27.10M(+8.1%)
Mar 2010
-
$25.06M(+4.0%)
Dec 2009
$102.88M(-47.0%)
$24.09M(-2.7%)
Sep 2009
-
$24.76M(-7.2%)
Jun 2009
-
$26.67M(-2.5%)
Mar 2009
-
$27.36M(-28.5%)
Dec 2008
$194.19M(-0.5%)
$38.25M(-4.3%)
Sep 2008
-
$39.97M(-33.2%)
Jun 2008
-
$59.84M(+6.6%)
Mar 2008
-
$56.14M(-20.9%)
Dec 2007
$195.18M(+68.3%)
$70.94M(+90.0%)
Sep 2007
-
$37.33M(-32.5%)
Jun 2007
-
$55.34M(+75.3%)
Mar 2007
-
$31.57M
Dec 2006
$115.94M(+56.1%)
-
Dec 2005
$74.29M
-

FAQ

  • What is Jazz Pharmaceuticals annual total operating expenses?
  • What is the all time high annual operating expenses for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals annual operating expenses year-on-year change?
  • What is Jazz Pharmaceuticals quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals quarterly operating expenses year-on-year change?

What is Jazz Pharmaceuticals annual total operating expenses?

The current annual operating expenses of JAZZ is $2.90B

What is the all time high annual operating expenses for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high annual total operating expenses is $2.90B

What is Jazz Pharmaceuticals annual operating expenses year-on-year change?

Over the past year, JAZZ annual total operating expenses has changed by +$95.56M (+3.41%)

What is Jazz Pharmaceuticals quarterly total operating expenses?

The current quarterly operating expenses of JAZZ is $849.11M

What is the all time high quarterly operating expenses for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high quarterly total operating expenses is $849.11M

What is Jazz Pharmaceuticals quarterly operating expenses year-on-year change?

Over the past year, JAZZ quarterly total operating expenses has changed by +$118.82M (+16.27%)
On this page